Cancer Care Northwest ( Site 0021) — Spokane, Washington

Cancer Care Northwest ( Site 0021) is a clinical research site located in Spokane, Washington, United States 99202.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cancer Care Northwest ( Site 0021) has participated in 1 clinical trials.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Care Northwest ( Site 0021)?

Cancer Care Northwest ( Site 0021) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Care Northwest ( Site 0021) conducted?

Cancer Care Northwest ( Site 0021) has 1 clinical trials on record. Their work covers Renal Cell Carcinoma.

Is Cancer Care Northwest ( Site 0021) accredited by Crixeo Health?

Cancer Care Northwest ( Site 0021) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cancer Care Northwest ( Site 0021)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.